DeltaMV

A Short History: How Pharma & Healthcare Market Research Evolved

By DeltaMV Insights TeamReviewed by DeltaMV Academy EditorialUpdated 6 min read

Module 1 · 3 of 10Foundations of Healthcare Market ResearchAll articles
  1. What Is Market Research, Really? A Beginner’s Map of the Field
  2. Why Healthcare Market Research Is Different From Consumer Research
  3. A Short History: How Pharma & Healthcare Market Research Evolved
  4. Ethics, Compliance & Data Privacy in Healthcare Market Research
  5. Types of Healthcare Market Research Studies: Trackers, Ad Hoc, Syndicated & Custom
  6. How a Market Research Project Actually Runs
  7. Qualitative vs Quantitative Research
  8. Primary vs Secondary Research
  9. Who’s Who: The Healthcare Ecosystem
  10. Common Myths About Market Research

Healthcare market research has evolved from informal physician feedback gathered by sales reps in the mid-20th century to today’s mix of digital tracking, behavioural science, and AI-assisted analysis. Each shift was driven by changes in regulation, technology, and how pharma companies needed to understand increasingly complex, multi-stakeholder treatment decisions.

Key Takeaways

  • The discipline grew out of informal sales-feedback loops long before it became a distinct discipline.
  • Regulation, from advertising rules to data privacy laws, has repeatedly forced the field to redesign how it collects and uses information.
  • The rise of digital channels and real-world data expanded what “research” even means, beyond surveys and interviews.
  • Behavioural science entered the field relatively recently, shifting focus from what people say to why they actually decide.
  • Understanding this history explains why today’s healthcare research looks the way it does. Every current practice is a response to something that came before it.

Why the History Matters

It’s easy to treat today’s research practices, such as compliance review, tracking studies, and discussion guide conventions, as fixed rules that have always existed. They haven’t. Each one is an adaptation to a specific problem the field ran into at some point. Seeing the timeline makes today’s practices easier to question, and easier to update, when the next shift comes.

  1. The Early Decades: Feedback From the Field (Pre-1980s)
  2. The Rise of Formal Methodology (1980s–1990s)
  3. Regulation Reshapes the Field (1990s–2000s)
  4. Digital and Data Expansion (2000s–2010s)
  5. Behavioural Science and AI (2010s–Today)

The Early Decades: Feedback From the Field (Pre-1980s)

Long before dedicated healthcare research firms existed, pharma companies relied on an informal channel: sales representatives reporting back what physicians said in the field. It wasn’t rigorous. Response bias was built in and there was no consistent methodology, but it was the only regular feedback loop companies had. As launches grew more expensive and competitive through the 1970s, that informality became a liability. Decisions worth millions of dollars were being shaped by anecdote, and companies began looking for something closer to an actual discipline.

The Rise of Formal Methodology (1980s–1990s)

This period saw structured physician surveys and advisory boards become standard practice, alongside the emergence of research firms specialising in healthcare rather than general consumer work. As managed care and formal reimbursement systems grew in markets like the US, payers and formularies started becoming a distinct stakeholder in their own right, not just an afterthought to the physician conversation. Qualitative research, especially interviews with physicians and key opinion leaders, became a standard step in message development ahead of a launch, rather than something done occasionally.

Regulation Reshapes the Field (1990s–2000s)

As advertising and promotion regulations tightened, including restrictions on off-label promotion, disclosure requirements, and stricter review of promotional claims, research questions themselves had to be redesigned to stay within what could legally be asked or implied. Data privacy laws, such as HIPAA in the US and comparable frameworks that followed in other markets, formalised how patient data could be collected, stored, and used in research. Compliance review stopped being a check applied only to marketing materials and became a standard step in the research process itself.

Digital and Data Expansion (2000s–2010s)

Online panels and digital surveys cut the cost and time of fieldwork compared to phone and in-person interviews, making larger and more frequent studies practical. At the same time, real-world data, such as claims data and, later, EHR-derived data, began supplementing primary research, particularly for tracking what physicians actually prescribed rather than what they said they intended to. Omnichannel engagement data, what content a physician actually opened, watched, or clicked, emerged as a new, passive research signal that didn’t require asking anyone anything at all.

Behavioural Science and AI (2010s–Today)

A growing body of evidence showed that stated intent in surveys often didn’t predict actual prescribing or treatment behaviour, a gap this Academy explores in depth in Module 2 and Module 3. Behavioural science frameworks were adopted specifically to explain and close that gap. More recently, AI-assisted analysis, natural language processing on open-ended responses, and even synthetic or simulated respondents, have started changing how fast and how deep research can go, while raising new questions about what counts as valid evidence.

What’s Still Genuinely Unsettled

How much weight to give AI-assisted or synthetic data, relative to real human respondents, is still being actively debated rather than settled. Regulatory frameworks in many markets are still catching up to digital and AI-driven research methods, leaving grey areas practitioners have to navigate case by case. And the field hasn’t converged on a single standard for combining passive behavioural data (what someone did) with traditional stated-preference research (what someone said), even though most practitioners agree both matter.

The Cheat Sheet

In one line: healthcare market research grew from “ask the sales rep what physicians think” into a discipline shaped by regulation, then expanded by digital data, and is now being reshaped again by behavioural science and AI. Each era added a tool. None of them fully replaced what came before.

A DeltaMV Perspective

While reviewing a legacy tracking study that had run largely unchanged for almost a decade, a DeltaMV team found the survey instrument was still asking questions designed for a market where digital channels barely existed. Physicians were being asked about print advertising recall in a market where most of their information now came from peer discussion and digital content. The study wasn’t wrong when it was built. Nobody had simply revisited its assumptions as the environment shifted around it. Updating it wasn’t about discarding the old data. It meant adding new questions alongside the old ones for a transition period, so the tracker could show both continuity and what had actually changed. Research instruments carry the assumptions of the era they were designed in, and need periodic revisiting, not just periodic re-fielding.

Composite/anonymized example; not a specific client or study.

FAQ

When did healthcare market research become its own discipline?

There’s no single date, but most practitioners point to the 1980s and 1990s, when structured physician surveys, advisory boards, and dedicated healthcare research firms became common, separate from informal sales feedback.

How did regulation change healthcare market research?

Advertising, promotion, and data privacy regulations introduced from the 1990s onward forced researchers to formalise compliance review, limit certain question types, and be far more careful about how patient data is collected and stored.

Is AI replacing traditional healthcare market research?

Not yet, and not entirely. AI is mostly being used to speed up analysis and, more experimentally, to simulate respondent behaviour, but most practitioners still treat it as a supplement to real fieldwork rather than a replacement.

Why does this history matter if I just need research done today?

Because today’s standard practices, like compliance review or combining tracking data with real-world data, exist for specific historical reasons. Knowing why a practice exists makes it easier to know when it’s safe to adapt it.

The Bottom Line

The field didn’t arrive at its current form all at once. It’s the sum of decades of adaptation to regulation, technology, and a deeper understanding of how people actually decide. The practices that feel standard today are responses to real problems from earlier eras, and the field is still adapting as digital data and AI reshape what’s possible.

What are you trying to change?

Let's explore the behavioural insight behind it.

Connect with us